While all youth with T1D are managed with insulin therapy, in this population, all participants with T2D were also utilizing insulin (and 35/41 (85%) of youth with T2D were utilizing basal/bolus insulin), suggesting that youth with T1D and T2D (on insulin) may experience a similar burden of management [16]. This evidence concerns the gene INS and type 1 diabetes mellitus.